Table 3. Relationship between serum adipocytokines levels (pg/mL) and clinicopathological features of lung cancer.
Clinicopathological parameters | IGFBP-1 | TNF RI | VEGF | TNF RII | BDNF | PAI-1 | IL-6 |
---|---|---|---|---|---|---|---|
Histology | |||||||
Adenocarcinoma | 158,243 | 47,944 | 12,449 | 55,344 | 55,768 | 14,434 | 12,452 |
Squamous cell | 175,741 | 40,599 | 12,483 | 46,102 | 42,168 | 12,497 | 12,135 |
Small cell carcinoma | 99,137 | 46,050 | 11,058 | 49,454 | 48,045 | 12,320 | 12,652 |
P value | 0.24 | 0.63 | 0.96 | 0.82 | 0.74 | 0.89 | 0.73 |
Tumor size | |||||||
≤3 cm | 142,571 | 43,508 | 12,378 | 42,374 | 65,235 | 16,820 | 13,377 |
3–5 cm | 150,059 | 35,629 | 9,223 | 48,704 | 44,592 | 11,894 | 11,463 |
>5 cm | 153,325 | 51,301 | 13,530 | 56,805 | 43,361 | 12,054 | 12,238 |
P value | 0.95 | 0.10 | 0.48 | 0.64 | 0.42 | 0.65 | 0.19 |
Lymphatic metastasis | |||||||
Positive | 150,259 | 46,861 | 11,898 | 51,247 | 47,688 | 13,936 | 12,194 |
Negative | 140,549 | 38,617 | 12,826 | 49,482 | 56,015 | 10,753 | 13,193 |
P value | 0.83 | 0.36 | 0.88 | 0.94 | 0.44 | 0.05 | 0.61 |
Distant metastasis | |||||||
Yes | 151,356 | 50,511 | 13,633 | 53,130 | 56,360 | 12,620 | 12,597 |
No | 143,895 | 36,783 | 9,977 | 47,775 | 46,193 | 14,539 | 12,140 |
P value | 0.05 | 0.03 | 0.33 | 0.10 | 0.57 | 0.30 | 0.27 |
TNM stage | |||||||
I | 147,430 | 30,024 | 12,086 | 43,820 | 56,692 | 11,614 | 12,300 |
II | 172,561 | 49,723 | 5,652 | 58,446 | 32,619 | 23,094 | 12,955 |
III | 108,157 | 37,363 | 10,084 | 45,015 | 38,771 | 11,836 | 11,005 |
IV | 151,356 | 50,511 | 13,633 | 53,130 | 56,360 | 12,620 | 12,597 |
P value | 0.31 | 0.08 | 0.37 | 0.16 | 0.32 | 0.71 | 0.07 |
Median values are given. Using the Kruskal-Wallis test calculate the P values). BMI, body mass index; NS Non-significant. IGFBP-1, insulin-like growth factor binding protein 1; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; IL, interleukin; BDNF, brain-derived neurotrophic factor; PAI-1, plasminogen activator inhibitor-1.